NMRA · Neumora Therapeutics, Inc. · Proposed Sales
$0.50
-0.03 (-4.84%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“While the Company expects to be able to obtain additional funding, the current available cash and cash equivalents will not be sufficient to fund the Company’s operating plans for at least twelve months from the issuance date of these condensed consolidated financial statements. Accordingly, the Company has concluded that substantial doubt exists about its ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$127.32M
Shares
187.90M
Volume · Oct 6
1.23M
Avg daily vol (3M)
1.17M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-08-21 | Aurora Daljit Singh | Officer | 41,608 | 2026-08-21 | Merrill Lynch |
| 2026-08-20 | Aurora Daljit Singh | Officer | 134,452 | 2026-08-20 | Merrill Lynch |
| 2026-08-19 | Aurora Daljit Singh | Officer | 61,918 | 2026-08-19 | Merrill Lynch |
| 2026-08-18 | Aurora Daljit Singh | Officer | 69,149 | 2026-08-18 | Merrill Lynch |
| 2026-08-17 | Aurora Daljit Singh | Officer | 146,706 | 2026-08-17 | Merrill Lynch |
| 2026-02-17 | Milligan Michael Lee | Officer | 1,436 | 2026-02-17 | Merrill Lynch |
| 2026-02-17 | BERNS PAUL L | Officer | 9,819 | 2026-02-17 | Merrill Lynch |
| 2026-02-17 | Pinto Joshua | Officer | 5,967 | 2026-02-17 | Merrill Lynch |
| 2026-02-17 | Aurora Daljit Singh | Officer | 6,165 | 2026-02-17 | Merrill Lynch |
| 2025-11-12 | Aurora Family Trust | Director, Officer | 114,703 | 2025-11-11 | Merrill Lynch |
| 2025-03-12 | Henry Gosebruch | Officer, Director | 15,000 | 2025-03-12 | J.P. Morgan Securities LLC |
| 2025-02-18 | Pinto Joshua | Officer | 8,048 | 2025-02-18 | Merrill Lynch |
| 2025-02-18 | Gosebruch Henry O | Officer, Director | 6,857 | 2025-02-18 | Merrill Lynch |
| 2025-02-18 | Aurora Daljit Singh | Officer | 8,565 | 2025-02-18 | Merrill Lynch |
| 2025-02-18 | Suh Carol Y. | Officer | 9,540 | 2025-02-18 | Merrill Lynch |
| 2025-02-18 | BERNS PAUL L | Officer | 13,871 | 2025-02-18 | Merrill Lynch |
| 2025-02-18 | Lenz Robert A. | Officer | 5,614 | 2025-02-18 | Merrill Lynch |
| 2025-02-18 | Milligan Michael Lee | Officer | 1,978 | 2025-02-18 | Merrill Lynch |
| 2024-10-18 | Fust Matthew K | Director | 14,049 | 2024-10-18 | Merrill Lynch |
| 2024-10-17 | Fust Matthew K | Director | 7,739 | 2024-10-17 | Merrill Lynch |
| 2024-10-10 | Lenz Robert A. | Officer | 8,260 | 2024-10-10 | Merrill Lynch |
| 2024-10-09 | Lenz Robert A. | Officer | 5,563 | 2024-10-09 | Merrill Lynch |
| 2024-09-18 | Lenz Robert A. | Officer | 10,676 | 2024-09-18 | Merrill Lynch |
| 2024-09-17 | Lenz Robert A. | Officer | 30,788 | 2024-09-17 | Merrill Lynch |
| 2024-09-12 | Lenz Robert A. | Officer | 32,948 | 2024-09-12 | Merrill Lynch |
| 2024-08-22 | Pinto Joshua | Officer | 100,000 | 2024-08-22 | Merrill Lynch |
Showing 1–26 of 26 filings